H.R. 2004

119th Congress

Reported

Tyler’s Law

Sponsored byDemocrat:Rep. Lieu, Ted [D-CA-36]CA· Introduced 10 March 2025
Open on Congress.gov

65

Cosponsors

19

Actions

0

Amendments

1

Committees

—

Since introduced

Step 1 of 0
Latest action

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 625.

16 September 2026·5 days ago

Summary

Introduced in House · Updated 3 September 2026

Tyler’s Law

This bill requires the Department of Health and Human Services (HHS) to complete, within one year after the bill’s enactment, a study on how frequently Medicare-participating hospital emergency departments test for fentanyl in patients experiencing an overdose, the costs associated with such testing, and how such testing may impact patients. 

Within six months after the study’s completion and based on its results, HHS must issue guidance regarding (1) whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, (2) how to ensure clinicians know which substances they are testing for in routine drug tests, and (3) how fentanyl testing may affect the future risk of overdose and other health outcomes.

Timeline

19 actions

  1. Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 625.

    16 September 2026 · Calendars

  2. DEBATE - The House proceeded with forty minutes of debate on H.R. 2004.

    15 September 2026 · Floor

  3. Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.

    15 September 2026 · Floor

  4. Mr. Guthrie moved to suspend the rules and pass the bill.

    15 September 2026 · Floor

  5. Considered under suspension of the rules.

    15 September 2026 · Floor

  6. Motion to reconsider laid on the table Agreed to without objection.

    15 September 2026 · Floor

  7. On motion to suspend the rules and pass the bill Agreed to by voice vote.

    15 September 2026 · Floor

  8. Mr. Guthrie moved to suspend the rules and pass the bill.

    15 September 2026 · Floor

  9. Reported by the Committee on Energy and Commerce. H. Rept. 119-817.

    14 September 2026 · Committee

  10. Reported by the Committee on Energy and Commerce. H. Rept. 119-817.

    14 September 2026 · Committee

  11. Placed on the Union Calendar, Calendar No. 716.

    14 September 2026 · Calendars

  12. Reported by the Committee on Energy and Commerce. H. Rept. 119-817.

    14 September 2026 · Committee

  13. Reported by the Committee on Energy and Commerce. H. Rept. 119-817.

    14 September 2026 · Committee

  14. Placed on the Union Calendar, Calendar No. 716.

    14 September 2026 · Calendars

  15. Reported by the Committee on Energy and Commerce. H. Rept. 119-817.

    14 September 2026 · Committee

  16. Ordered to be Reported by the Yeas and Nays: 46 - 0.

    21 July 2026 · Committee

  17. Committee Consideration and Mark-up Session Held

    21 July 2026 · Committee

  18. Ordered to be Reported by the Yeas and Nays: 46 - 0.

    21 July 2026 · Committee

  19. Committee Consideration and Mark-up Session Held

    21 July 2026 · Committee

  20. Committee Consideration and Mark-up Session Held

    21 July 2026 · Committee

Sponsorship

65 cosponsors

Sponsor

Democrat:Rep. Lieu, Ted [D-CA-36]CA

Cosponsors

  • Democrat2448%
  • Republican2652%
View all on Congress.gov

Classification

Policy area

Health

Legislative subjects

Drug, alcohol, tobacco useEmergency medical services and trauma careGovernment information and archivesGovernment studies and investigationsHospital careMedical tests and diagnostic methods

Committees

1

  • Energy and Commerce Committee

    House · Standing

    • Referred To10 Mar 2025
    • Markup By20 Jul 2026
    • Markup By21 Jul 2026

    • Health Subcommittee

      • Referred to10 Mar 2025
      • Markup by25 Jun 2026
      • Reported by25 Jun 2026
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.